$99,315,090

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to PARTNER THERAPEUTICS, INC.

healthactiveONGOING · MOD OF 2023 CONTRACT

WORK BEGAN2023-09-26·LATEST ACTION2026-03-26·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50323F80027_7505_36F79723D0171_3600

Award description

LEUKINE 250MCG VIL INJ (5PKG)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Procurement of Leukine (sargramostim) injectable medication for emergency preparedness and response stockpiling.

Sub-sectors

pharmaceutical-procurementemergency-preparednessbiodefense

Why this matters

ASPR maintains strategic medical countermeasures for biological/radiological emergencies; Leukine treats bone marrow damage from radiation exposure.

Supply-chain signal

Large bulk purchase signals government stockpiling of critical hematopoietic agents; may indicate capacity planning for radiological/nuclear contingencies.

U.S.–China competition angle

Biodefense pharmaceutical independence; ensures U.S. access to critical medical countermeasures outside potential supply chain disruptions.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002240.

Period of performance

Start

2023-09-26

End

2027-03-29

Status

activein 316 days

Recipient

PARTNER THERAPEUTICS, INC.

UEI J33MSDBJZMC6

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50323F80027_7505_36F79723D0171_3600.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.